Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-25-019644
Filing Date
2025-06-06
Accepted
2025-06-06 09:51:40
Documents
1
Period of Report
2025-06-05

Document Format Files

Seq Description Document Type Size
1 FORM 4 rdgdoc.html 4  
1 FORM 4 rdgdoc.xml 4 3862
  Complete submission text file 0001437749-25-019644.txt   5549
Mailing Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA GA 30080
Business Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA GA 30080 678-384-7220
GeoVax Labs, Inc. (Issuer) CIK: 0000832489 (see all company filings)

EIN.: 870455038 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 3 MURRAY HILL ROAD SCARSDALE NY 10583
Business Address
Lemerond Nicole (Reporting) CIK: 0001941712 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39563 | Film No.: 251029140